🇺🇸 FDA
Patent

US 11156612

Methods of determining levels of cleaved and/or intact kininogen

granted A61KA61K39/3955A61P

Quick answer

US patent 11156612 (Methods of determining levels of cleaved and/or intact kininogen) held by Takeda Pharmaceutical Company Limited expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K39/3955, A61P, A61P1/04, A61P17/00